Vijoice
RxNorm concept 2598454, brand name (bn).
- RxCUI
- 2598454
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2598454 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- alpelisib 50 MG [Vijoice] (SBDC, ingredient of)
- Vijoice Oral Product (SBDG, ingredient of)
- Vijoice Pill (SBDG, ingredient of)
- alpelisib Oral Tablet [Vijoice] (SBDF, ingredient of)
- alpelisib 50 MG Oral Tablet [Vijoice] (SBD, ingredient of)
- alpelisib 125 MG [Vijoice] (SBDC, ingredient of)
- alpelisib 125 MG Oral Tablet [Vijoice] (SBD, ingredient of)
- alpelisib 200 MG [Vijoice] (SBDC, ingredient of)
- alpelisib 200 MG Oral Tablet [Vijoice] (SBD, ingredient of)
- Vijoice Granule Product (SBDG, ingredient of)
- alpelisib Oral Granules [Vijoice] (SBDF, ingredient of)
- alpelisib 50 MG Oral Granules [Vijoice] (SBD, ingredient of)
- alpelisib (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2598454 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2598454 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2598454. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.